PT - JOURNAL ARTICLE AU - Junko Kurita AU - Tamie Sugawara AU - Yasushi Ohkusa TI - Interim evaluation of Google AI forecasting for COVID-19 compared with statistical forecasting by human intelligence in the first week AID - 10.1101/2020.12.16.20248358 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.16.20248358 4099 - http://medrxiv.org/content/early/2020/12/18/2020.12.16.20248358.short 4100 - http://medrxiv.org/content/early/2020/12/18/2020.12.16.20248358.full AB - Background Since June, Google (Alphabet Inc.) has provided forecasting for COVID-19 outbreak by artificial intelligence (AI) in the USA. In Japan, they provided similar services from November, 2020.Object We compared Google AI forecasting with a statistical model by human intelligence.Method We regressed the number of patients whose onset date was day t on the number of patients whose past onset date was 14 days prior, with information about traditional surveillance data for common pediatric infectious diseases including influenza, and prescription surveillance 7 days prior. We predicted the number of onset patients for 7 days, prospectively. Finally, we compared the result with Googles AI-produced forecast. We used the discrepancy rate to evaluate the precision of prediction: the sum of absolute differences between data and prediction divided by the aggregate of data.Results We found Google prediction significantly negative correlated with the actual observed data, but our model slightly correlated but not significant. Moreover, discrepancy rate of Google prediction was 27.7% for the first week. The discrepancy rate of our model was only 3.47%.Discussion and Conclusion Results show Googles prediction has negatively correlated and greater difference with the data than our results. Nevertheless, it is noteworthy that this result is tentative: the epidemic curve showing newly onset patients was not fixed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All information used for this study has been published. There is therefore no ethical issue related to this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases. Japan: COVID-19 Public Forecasts - Data Studio https://www.mhlw.go.jp/stf/newpage_10723.html https://datastudio.google.com/reporting/8224d512-a76e-4d38-91c1-935ba119eb8f